Toyota Motor Corporation continues to operate across manufacturing, mobility development, and transportation innovation. Market participation connects Toyota with broader movements across global ...
The House panel wants to question Bondi about the DOJ's compliance with the Epstein Files Transparency Act, which President ...
A group of Democratic lawmakers is warning that changes at the SSA are pushing its customer service system into crisis.
In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...
Delhi-based CD Foundation blames "unscrupulous" agent for fraud; Auckland organisers claim no knowledge of visa applications.
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced ...
The more things change, the more they stay the same ...
The US Food and Drug Administration (FDA) has issued a Complete Response Letter to Aldeyra Therapeutics for its New Drug Application of reproxalap for the treatment of dry eye dis ...
In San Jose, where the family home of Cesar Chavez is a cultural landmark, many are devastated by allegations about Chavez ...
Alphabet (GOOGL) completes its largest acquisition ever, purchasing cybersecurity firm Wiz for $32 billion to enhance Google ...
FDA rejection was attributed to a lack of substantial evidence of efficacy, including inconsistencies that undermined confidence in reproducibility across investigations. Reproxalap targets reactive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results